|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Gastrointestinal cancer
Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of
Hepatocellular Carcinoma
Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria
Ja Kyung Yoon, Dai Hoon Han, Sunyoung Lee, Jin-Young Choi, Gi Hong Choi, Do Young Kim, Myeong-Jin Kim
Cancer Res Treat.
2023;55(3):939-947. Published online February 10, 2023 DOI:
https://doi.org/10.4143/crt.2022.1645
Hepatitis B Virus Core Protein Mediates the Upregulation of C5α Receptor 1 via NF-κB Pathway to Facilitate the Growth and Migration of Hepatoma Cells
Fanyun Kong, Yukai Tao, Dongchen Yuan, Ning Zhang, Qi Li, Tong Yu, Xiaoying Yang, Delong Kong, Xiaohui Ding, Xiangye Liu, Hongjuan You, Kuiyang Zheng, Renxian Tang
Cancer Res Treat.
2021;53(2):506-527. Published online November 16, 2020 DOI:
https://doi.org/10.4143/crt.2020.397
Cited By 7
Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar
Hepatocellular Carcinoma
: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers
Jeong-Seon Lee, Hye Young Jin, Jung Min Ko, Seoung Hoon Kim, Nayoung Han, Byung Kiu Park, Meerim Park, Hyeon Jin Park, Jun Ah Lee
Cancer Res Treat.
2021;53(1):283-288. Published online September 7, 2020 DOI:
https://doi.org/10.4143/crt.2020.575
Cited By 9
Gastrointestinal cancer
Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for
Hepatocellular Carcinoma
in 1,008 Patients with Curative Resection
Sujin Park, Sangjoon Choi, Yoon Ah Cho, Dong Hyun Sinn, Jong Man Kim, Cheol-Keun Park, Sang Yun Ha
Cancer Res Treat.
2020;52(4):1145-1152. Published online April 28, 2020 DOI:
https://doi.org/10.4143/crt.2020.208
Cited By 15
Prognostic Value of
TP53
Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced
Hepatocellular Carcinoma
Miao Xue, Yanqin Wu, Wenzhe Fan, Jian Guo, Jialiang Wei, Hongyu Wang, Jizhou Tan, Yu Wang, Wang Yao, Yue Zhao, Jiaping Li
Cancer Res Treat.
2020;52(3):925-937. Published online March 30, 2020 DOI:
https://doi.org/10.4143/crt.2019.533
Cited By 9
Soluble Axl Is a Novel Diagnostic Biomarker of
Hepatocellular Carcinoma
in Chinese Patients with Chronic Hepatitis B Virus Infection
Xiaoting Song, Ailu Wu, Zhixiao Ding, Shixiong Liang, Chunyan Zhang
Cancer Res Treat.
2020;52(3):789-797. Published online March 5, 2020 DOI:
https://doi.org/10.4143/crt.2019.749
Cited By 12
Activation of Tyrosine Metabolism in CD13
+
Cancer Stem Cells Drives Relapse in
Hepatocellular Carcinoma
Li Sun, Lin Zhang, Jun Chen, Chaoqun Li, Hongqin Sun, Jiangrong Wang, Hong Xiao
Cancer Res Treat.
2020;52(2):604-621. Published online December 27, 2019 DOI:
https://doi.org/10.4143/crt.2019.444
Cited By 20
Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in
Hepatocellular Carcinoma
Guo-Pei Zhang, Xiao Yue, Shao-Qiang Li
Cancer Res Treat.
2020;52(1):10-23. Published online April 26, 2019 DOI:
https://doi.org/10.4143/crt.2019.145
Cited By 30
Treatment Outcome after Fractionated Conformal Radiotherapy for
Hepatocellular Carcinoma
in Patients with Child-Pugh Classification B in Korea (KROG 16-05)
Sun Hyun Bae, Hee Chul Park, Won Sup Yoon, Sang Min Yoon, In-Hye Jung, Ik Jae Lee, Jun Won Kim, Jinsil Seong, Tae Hyun Kim, Taek-Keun Nam, Youngmin Choi, Sun Young Lee, Hong Seok Jang, Dong Soo Lee, Jin Hee Kim
Cancer Res Treat.
2019;51(4):1589-1599. Published online April 10, 2019 DOI:
https://doi.org/10.4143/crt.2018.687
Cited By 15
Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with
Hepatocellular Carcinoma
Underwent Hepatectomy
Yifei Wang, Kaiyu Sun, Jingxian Shen, Bin Li, Ming Kuang, Qinghua Cao, Sui Peng
Cancer Res Treat.
2019;51(4):1464-1478. Published online March 11, 2019 DOI:
https://doi.org/10.4143/crt.2018.657
Cited By 22
Surveillance Rate and its Impact on Survival of
Hepatocellular Carcinoma
Patients in South Korea: A Cohort Study
Sanghyuk Im, Eun Sun Jang, Ju Hyun Lee, Chung Seop Lee, Beom Hee Kim, Jung Wha Chung, Jin-Wook Kim, Sook-Hyang Jeong
Cancer Res Treat.
2019;51(4):1357-1369. Published online February 12, 2019 DOI:
https://doi.org/10.4143/crt.2018.430
Cited By 4
Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced
Hepatocellular Carcinoma
Changhoon Yoo, Jihoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoo
Cancer Res Treat.
2019;51(2):510-518. Published online June 13, 2018 DOI:
https://doi.org/10.4143/crt.2018.226
Cited By 31
Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B)
Hepatocellular Carcinoma
Patients
Zhang Zhaohui, Shen Shunli, Chen Bin, Li Shaoqiang, Hua Yunpeng, Kuang Ming, Liang Lijian, Peng Bao Gang
Cancer Res Treat.
2019;51(1):65-72. Published online February 26, 2018 DOI:
https://doi.org/10.4143/crt.2018.038
Cited By 15
Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against
Hepatocellular Carcinoma
Cells through the Paradoxical Inhibition of Autophagy
Sang Chul Lee, Kee-Hwan Kim, Ok-Hee Kim, Sang Kuon Lee, Ha-Eun Hong, Byung Jo Choi, Wonjun Jeong, Say-June Kim
Cancer Res Treat.
2018;50(3):1023-1038. Published online November 9, 2017 DOI:
https://doi.org/10.4143/crt.2017.085
Cited By 6
Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed
Hepatocellular Carcinoma
, Independent of Tumor Stage and Liver Function
Yeonjung Ha, Daejung Kim, Seungbong Han, Young Eun Chon, Yun Bin Lee, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
Cancer Res Treat.
2018;50(3):843-851. Published online September 4, 2017 DOI:
https://doi.org/10.4143/crt.2017.232
Cited By 34
Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with
Hepatocellular Carcinoma
Eun-Jung Lee, Seung-Hyun Yang, Kyoung-Jin Kim, Hyejung Cha, Seo Jin Lee, Ji-Hye Kim, Junkyu Song, Kyung-Hee Chun, Jinsil Seong
Cancer Res Treat.
2018;50(3):646-657. Published online July 17, 2017 DOI:
https://doi.org/10.4143/crt.2016.550
Cited By 11
Body Composition Predicts Survival in Patients with
Hepatocellular Carcinoma
Treated with Transarterial Chemoembolization
Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su
Cancer Res Treat.
2018;50(2):530-537. Published online June 1, 2017 DOI:
https://doi.org/10.4143/crt.2017.156
Cited By 20
Sub-classification of Advanced-Stage
Hepatocellular Carcinoma
: A Cohort Study Including 612 Patients Treated with Sorafenib
Jeong-Ju Yoo, Goh Eun Chung, Jeong-Hoon Lee, Joon Yeul Nam, Young Chang, Jeong Min Lee, Dong Ho Lee, Hwi Young Kim, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Seoul Liver Group
Cancer Res Treat.
2018;50(2):366-373. Published online May 15, 2017 DOI:
https://doi.org/10.4143/crt.2017.126
Cited By 14
Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with
Hepatocellular Carcinoma
Hae Il Jung, Dongjun Jeong, Sanghee Ji, Tae Sung Ahn, Sang Ho Bae, Susie Chin, Jun Chul Chung, Hyung Chul Kim, Moon Soo Lee, Moo-Jun Baek
Cancer Res Treat.
2017;49(1):246-254. Published online July 7, 2016 DOI:
https://doi.org/10.4143/crt.2016.066
Cited By 131
Studying the Effect of Downregulating Autophagy-Related Gene LC3 on TLR3 Apoptotic Pathway Mediated by dsRNA in
Hepatocellular Carcinoma
Cells
Guilan Wang, Maona Zhang, Yunlong Li, Jiaming Zhou, Li Chen
Cancer Res Treat.
2017;49(1):230-245. Published online June 13, 2016 DOI:
https://doi.org/10.4143/crt.2015.506
Cited By 3
Clinical Practice Patterns of Radiotherapy in Patients with
Hepatocellular Carcinoma
: A Korean Radiation Oncology Group Study (KROG 14-07)
Hyejung Cha, Hee Chul Park, Jeong Il Yu, Tae Hyun Kim, Taek-Keun Nam, Sang Min Yoon, Won Sup Yoon, Jun Won Kim, Mi Sook Kim, Hong Seok Jang, Youngmin Choi, Jin Hee Kim, Chul Seung Kay, Inkyung Jung, Jinsil Seong
Cancer Res Treat.
2017;49(1):61-69. Published online June 13, 2016 DOI:
https://doi.org/10.4143/crt.2016.097
Cited By 11
Estimation of the Incidence of
Hepatocellular Carcinoma
and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method
Seesai Yeesoonsang, Surichai Bilheem, Edward McNeil, Sophon Iamsirithaworn, Chuleeporn Jiraphongsa, Hutcha Sriplung
Cancer Res Treat.
2017;49(1):54-60. Published online May 18, 2016 DOI:
https://doi.org/10.4143/crt.2016.045
Cited By 5
Real-Life Experience of Sorafenib Treatment for
Hepatocellular Carcinoma
in Korea: From GIDEON Data
Do Young Kim, Hye Jin Kim, Kwang-Hyub Han, Sang Young Han, Jeong Heo, Hyun Young Woo, Soon Ho Um, Yeul Hong Kim, Young Oh Kweon, Ho Yeong Lim, Jung Hwan Yoon, Wan Sik Lee, Byung Seok Lee, Han Chu Lee, Baek-Yeol Ryoo, Seung Kew Yoon
Cancer Res Treat.
2016;48(4):1243-1252. Published online February 24, 2016 DOI:
https://doi.org/10.4143/crt.2015.278
Cited By 14
A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer
Soo Jeong Nam, Hyun Yang Yeo, Hee Jin Chang, Bo Hyun Kim, Eun Kyung Hong, Joong-Won Park
Cancer Res Treat.
2016;48(4):1229-1242. Published online March 30, 2016 DOI:
https://doi.org/10.4143/crt.2015.500
Cited By 12
The Overexpression of CCAR1 in
Hepatocellular Carcinoma
Associates with Poor Prognosis
Sang Yun Ha, Jeong Hoon Kim, Jung Wook Yang, Jimin Kim, Binnari Kim, Cheol-Keun Park
Cancer Res Treat.
2016;48(3):1065-1073. Published online October 16, 2015 DOI:
https://doi.org/10.4143/crt.2015.302
Cited By 10
Do Biliary Complications after Hypofractionated Radiation Therapy in
Hepatocellular Carcinoma
Matter?
Jeong Il Yu, Hee Chul Park, Do Hoon Lim, Seung Woon Paik
Cancer Res Treat.
2016;48(2):574-582. Published online July 17, 2015 DOI:
https://doi.org/10.4143/crt.2015.076
Cited By 10
Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced
Hepatocellular Carcinoma
: A Propensity Score Matching Analysis
Hong In Yoon, Ki Jun Song, Ik Jae Lee, Do Young Kim, Kwang-Hyub Han, Jinsil Seong
Cancer Res Treat.
2016;48(1):190-197. Published online March 5, 2015 DOI:
https://doi.org/10.4143/crt.2014.276
Cited By 13
The Prognostic Role of Mitotic Index in
Hepatocellular Carcinoma
Patients after Curative Hepatectomy
Sang Yun Ha, Misun Choi, Taebum Lee, Cheol-Keun Park
Cancer Res Treat.
2016;48(1):180-189. Published online March 18, 2015 DOI:
https://doi.org/10.4143/crt.2014.321
Cited By 14
ATAD2 as a Poor Prognostic Marker for
Hepatocellular Carcinoma
after Curative Resection
Hye Won Hwang, Sang Yun Ha, Heejin Bang, Cheol-Keun Park
Cancer Res Treat.
2015;47(4):853-861. Published online February 16, 2015 DOI:
https://doi.org/10.4143/crt.2014.177
Cited By 30
Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in
Hepatocellular Carcinoma
Heejin Bang, Sang Yun Ha, Soo Hyun Hwang, Cheol-Keun Park
Cancer Res Treat.
2015;47(4):844-852. Published online February 13, 2015 DOI:
https://doi.org/10.4143/crt.2014.124
Cited By 28
1
2
3
Journal Impact Factor 4.6